key: cord-0963153-09j5zo5w
authors: Sivaloganathan, A.A.; Nasim-Mohi, M.; Brown, M.M.; Abdul, N.; Jackson, S.; Fletcher, S.V.; Gupta, S.; Grocott, M.P.; Dushianthan, A.
title: Noninvasive ventilation for COVID-19 associated acute hypoxaemic respiratory failure: experience from a single centre
date: 2020-07-21
journal: Br J Anaesth
DOI: 10.1016/j.bja.2020.07.008
sha: de0c68f3f96aea3c959fc088333eb9caeb642ee6
doc_id: 963153
cord_uid: 09j5zo5w

nan

SARS-CoV-2 from admission to discharge across all levels of care): REC Reference; 17/NW/0632, SRB Reference Number; SRB0025. Informed consent was waived because of the study design.

Consecutive patients diagnosed with COVID-19 based on laboratory reverse transcriptase polymerase chain reaction (RT-PCR) tests and with associated AHRF were assessed from hospital admission to establish suitability for invasive mechanical ventilation and/or noninvasive ventilation in the event of severe respiratory failure. Indications for escalation of care to noninvasive ventilation/invasive mechanical ventilation were based on respiratory distress, gas exchange, other organ dysfunction and the rate of change in their clinical condition. Patients who were candidates for escalation to invasive mechanical ventilation were admitted to the general intensive care unit (Cohort 1). Patients in whom noninvasive ventilation was defined as the ceiling of ventilation care were admitted to a level 2 area (Cohort 2). Data were collected from existing electronic hospital records, from the index patient (06/03/2020) until 16.00 on 14/05/2020. For descriptive statistics, data were presented as median (25 th -75 th centiles) as variables were found to be non-normally distributed when assessed by the Kolmogorov-Smirnov test. Comparison of proportions was performed using Chi-squared testing.

Unadjusted univariate logistic regression was performed to obtain a non-adjusted odds ratios and 95% confidence intervals (CI) for important variables.

A total of 586 confirmed COVID-19 positive patients were hospitalized during the study period, of whom 103 (17.6%) required noninvasive ventilation or invasive mechanical ventilation. Of these, 79 were admitted to the ICU to receive noninvasive ventilation or invasive mechanical ventilation (Cohort 1), and 24 were admitted to a separate level 2 area for noninvasive ventilation support as a ceiling of ventilatory care (Cohort 2). Cohort 2 patients were older (median age 67 yr), more frail [median Rockwood clinical frailty scale (CFS) of 6] 6 , had more comorbidities [median Charlson comorbidity index (CCI) of 4] 7 and were more hypoxic when care was escalated to noninvasive ventilation (Table 1) .

Among Cohort 1 patients, 58/79 (73%) had an initial trial of noninvasive ventilation whilst 21/79 (27%) underwent immediate tracheal intubation (Group IMV alone). Among those patients who has an initial trial of noninvasive ventilation, 27/58 progressed to invasive mechanical ventilation (Group NIV+IMV) whereas 31/58 did not require subsequent invasive mechanical ventilation (Group NIV alone). Of note, 29/31 (94%) patients in Group NIV alone were discharged from hospital alive with the remaining 2/31 (6%) being alive in ICU at the time of data collection. Of Cohort 2 patients, 4/24 (17%) were discharged from hospital alive whereas 20/24 (83%) died in hospital. In Group NIV + IMV, the median time to invasive mechanical ventilation was 17 h (4-31) and 55% failed within first 24 h. For Group NIV alone, median noninvasive ventilation duration was 3 days.

Median age for patients in Group NIV alone was 50 yr compared to 57 yr in Group NIV+IMV. CFS, Charlson Co-Morbidity Index, APACHE II and SOFA scores were similar between these two groups.

The only variable associated with risk of intubation was the admission SOFA score. In all patients who underwent a trial of noninvasive ventilation (Group NIV alone and Group NIV+IMV), univariate unadjusted logistic regression analysis showed increased SOFA scores on admission was associated with increased risk if tracheal intubation (OR 2.4 95% CI 1.34-4.38, P<0.0001). Among the patients eligible for escalation to invasive mechanical ventilation, the overall mortality was 9/61 (14%) cases with completed ICU episodes and 9/79 (11%) of all admitted cases including those remaining on ICU. Overall, 23 patients (30%) remained hospitalized either in ICU (20%) or on medical wards (10%) and 45 patients (57%) had been successfully discharged home. Two patients were transferred to another tertiary hospital for extracorporeal membrane oxygenation. Substantially higher mortality (83%) was noted among those patients who received noninvasive ventilation as ceiling of care.

Comparisons with published national critical care data for England Wales and Northern Ireland from the Intensive Care National Audit and Research Centre (ICNARC) provide interesting context to our data. It is important to emphasise that such comparisons are limited by the absence of comprehensive matching of the characteristics of our patients with those within the ICNARC dataset. APACHE-II and PaO 2 /FiO 2 ratios for Cohort 1 (eligible for escalation to invasive mechanical ventilation) were similar to the ICNARC cohort. However, the use of basic respiratory support (noninvasive ventilation) was more common (73.4% for Cohort 1 vs. 56.7% ICNARC). 1 In comparison with ICNARC mortality from completed episodes (discharged from hospital or dead) (3139/6860; 45.8%), there was a smaller proportion of deaths in all groups except for Cohort 2 (noninvasive ventilation as limit of ventilatory care): Overall mortality 29/85 (34.1%); Cohort 1 mortality 9/61 (14.6%). 1

Despite the widespread use of noninvasive ventilation for the treatment of acute hypoxaemic respiratory failure and acute respiratory distress syndrome, its utility in COVID-19 lung disease remains controversial. 4, 5, 8 We report on 103 critically-ill patients with COVID-19 and moderatesevere hypoxaemic respiratory failure including 24 patients who were offered noninvasive ventilation as a ceiling of ventilatory care. More than half of the patients eligible for escalation to invasive mechanical ventilation tolerated noninvasive ventilation well and avoided tracheal intubation at any time.

Unsurprisingly, the mortality and clinical outcome of these patients were better than those patients who were subsequently intubated. In conclusion, noninvasive ventilation is a safe, feasible and useful ventilatory strategy that may avoid the complications of tracheal intubation and ventilation in selected patients with COVID-19 associated respiratory failure. Our data from a single centre suggest that noninvasive ventilation has a role in the management of COVID-19 associated respiratory failure, but 

The Case Mix Programme is the national clinical audit of patient outcomes from adult critical care coordinated by the Intensive Care National Audit & Research Centre (ICNARC). For more information for the representativeness and quality of these data, please contact ICNARC

Clinical Characteristics of 138 Hospitalized Patients with

Novel Coronavirus-Infected Pneumonia in Wuhan, China

Covid-19 in Critically Ill Patients in the Seattle Region -Case Series

Clinical characteristics of coronavirus disease 2019 in China

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

A global clinical measure of fitness and frailty in elderly people

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome. Insights from the LUNG SAFE Study